成立年份: 1965
总资产(USD): 65,000,000至69,999,999
员工总人数: 500以上
主要竞争优势: 国际认证/标准,发货速度,生产能力,合同定制,接受买家的规格要求,优质服务
其他竞争优势:
专利与版权:
业务类型: 制造商,出口商,进口商
年销售额(USD): 100,000,000至249,999,999
主要销售市场: 中/南美洲,西欧,东欧,亚洲,中东,非洲
主要产品类别: 原料药,中间体,生物制品,天然提取物,药品制剂,包材及给药装置
所有产品: 头孢类,培南类,b内酰胺类 pharmaceutical intermediates, API, and Finished Dosage Forms (FDF).
外销比重: 30
内销比重: 70
主要客户:
合同定制: CRO,CMO
付款条款:
XINXING CATHAY INTERNATIONAL GROUP • Hainan Haiyao Co., Ltd (Hereinafter referred to as Haiyao) was founded in 1965 and became a mixed ownership enterprise controlled by a central state-owned enterprise XINXING CATHAY INTERNATIONAL GROUP in March, 2020.
Haiyao is now a large pharmaceutical group in China with more than 10 subsidiaries enterprises. Its business scope covers research and development, manufacturing, and trading business.
Our main products include pharmaceutical intermediates, API, finished dosage forms (FDF), Chinese patent medicine, biological drug, high-end medical devices etc., focusing on high value-added generic drugs and specific medicines.
重庆市忠县忠州大道沈阳路1号